Dan Turner
Presidente en GC Aesthetics Plc .
Relaciones activas
| Nombre | Sexo | Edad | Empresas relacionadas | Colaboración |
|---|---|---|---|---|
| Jeff Bedard | M | - |
Crown Laboratories, Inc.
 Crown Laboratories, Inc. Pharmaceuticals: OtherHealth Technology Crown Laboratories, Inc. provides pharmaceutical and consumer products. Its products include aesthetics, beauty, therapeutic and prescription products. The firm offers contract development, manufacturing, production and packaging servicers. The company was founded by Don Kilday and Jeff Bedard in November 2000 and is headquartered in Johnson City, TN. | 24 años |
| Orestes L. Lugo | M | - |
Pure Life Renal, Inc.
 Pure Life Renal, Inc. Medical/Nursing ServicesHealth Services Pure Life Renal, Inc. provides dialysis services. The firm offers the business and operational management tools along with the administrative structure that enable physicians to concentrate on care in a managed environment. The company was founded by Stefano Ciampolini in 2013 and is headquartered in Hollywood, FL. | - |
| Michael Matly | M | 42 |
Montreux Equity Partners, Inc.
 Montreux Equity Partners, Inc. Investment ManagersFinance Montreux Equity Partners, Inc. (Montreux Equity Partners) is a Venture Capital firm founded in 1993 by Dan K. Turner. The firm is headquartered in San Francisco, California.
Pure Life Renal, Inc.
Pure Life Renal, Inc. Medical/Nursing ServicesHealth Services Pure Life Renal, Inc. provides dialysis services. The firm offers the business and operational management tools along with the administrative structure that enable physicians to concentrate on care in a managed environment. The company was founded by Stefano Ciampolini in 2013 and is headquartered in Hollywood, FL. | - |
| Mariano García-Valiño | M | 58 |
GC Aesthetics Plc
 GC Aesthetics Plc Medical SpecialtiesHealth Technology GC Aesthetics Plc designs, manufactures and distribute implantable medical devices. The firm operates through two brands: Nagor and Eurosilicone. Its global aesthetics products market includes the following segments: breast implant products, skin tightening and body shaping, energy devices, neuro modulators, dermal fillers, chemical peels, liposuctions, self and physician dispensed topical and injectables, removal of localized fat deposits, device-based alternatives to toxins for wrinkle reduction and therapy treatments for hair loss, excessive sweating (hyperhidrosis), malfunctioning veins (sclerotherapy) and scars. The company was founded by William McCabe in April 2015 and is headquartered in Dublin, Ireland.
moksha8 Pharmaceuticals, Inc.
 moksha8 Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology moksha8 Pharmaceuticals, Inc. operates as a pharmaceutical company. It's products include viibryd, razapina, queopine, benexafrina, arasid, ziledon, zopina, and rispalum. The firm offers a portfolio of therapeutics for bipolar disorders and schizophrenia. The company was founded by Balkrishan Gill in 2007 and is headquartered in Berwyn, PA. | 6 años |
| Michel Rouif | M | 63 |
GC Aesthetics Plc
GC Aesthetics Plc Medical SpecialtiesHealth Technology GC Aesthetics Plc designs, manufactures and distribute implantable medical devices. The firm operates through two brands: Nagor and Eurosilicone. Its global aesthetics products market includes the following segments: breast implant products, skin tightening and body shaping, energy devices, neuro modulators, dermal fillers, chemical peels, liposuctions, self and physician dispensed topical and injectables, removal of localized fat deposits, device-based alternatives to toxins for wrinkle reduction and therapy treatments for hair loss, excessive sweating (hyperhidrosis), malfunctioning veins (sclerotherapy) and scars. The company was founded by William McCabe in April 2015 and is headquartered in Dublin, Ireland.
Global Consolidated Aesthetics Ltd.
 Global Consolidated Aesthetics Ltd. Medical SpecialtiesHealth Technology Global Consolidated Aesthetics Ltd. develops, manufactures and sells breast implants. It offers products under flagship brands Nagor and Eurosilicone. The firm manufactures products at its own facilities based in Scotland, England and France and produces to the highest European standards. The company was founded in 2007 and is headquartered in Dublin, Ireland. | 9 años |
| Solomon David | M | 57 |
Crown Laboratories, Inc.
Crown Laboratories, Inc. Pharmaceuticals: OtherHealth Technology Crown Laboratories, Inc. provides pharmaceutical and consumer products. Its products include aesthetics, beauty, therapeutic and prescription products. The firm offers contract development, manufacturing, production and packaging servicers. The company was founded by Don Kilday and Jeff Bedard in November 2000 and is headquartered in Johnson City, TN. | - |
| Joel Barlan | M | - |
moksha8 Pharmaceuticals, Inc.
moksha8 Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology moksha8 Pharmaceuticals, Inc. operates as a pharmaceutical company. It's products include viibryd, razapina, queopine, benexafrina, arasid, ziledon, zopina, and rispalum. The firm offers a portfolio of therapeutics for bipolar disorders and schizophrenia. The company was founded by Balkrishan Gill in 2007 and is headquartered in Berwyn, PA. | 10 años |
| Jessica Hou | F | - |
Montreux Equity Partners, Inc.
Montreux Equity Partners, Inc. Investment ManagersFinance Montreux Equity Partners, Inc. (Montreux Equity Partners) is a Venture Capital firm founded in 1993 by Dan K. Turner. The firm is headquartered in San Francisco, California. | 12 años |
| Nadeem Moiz | M | 53 |
Crown Laboratories, Inc.
Crown Laboratories, Inc. Pharmaceuticals: OtherHealth Technology Crown Laboratories, Inc. provides pharmaceutical and consumer products. Its products include aesthetics, beauty, therapeutic and prescription products. The firm offers contract development, manufacturing, production and packaging servicers. The company was founded by Don Kilday and Jeff Bedard in November 2000 and is headquartered in Johnson City, TN. | 2 años |
| Stefano Ciampolini | M | 55 |
Pure Life Renal, Inc.
Pure Life Renal, Inc. Medical/Nursing ServicesHealth Services Pure Life Renal, Inc. provides dialysis services. The firm offers the business and operational management tools along with the administrative structure that enable physicians to concentrate on care in a managed environment. The company was founded by Stefano Ciampolini in 2013 and is headquartered in Hollywood, FL. | 11 años |
| Carlos Reis Pinto | M | - |
GC Aesthetics Plc
GC Aesthetics Plc Medical SpecialtiesHealth Technology GC Aesthetics Plc designs, manufactures and distribute implantable medical devices. The firm operates through two brands: Nagor and Eurosilicone. Its global aesthetics products market includes the following segments: breast implant products, skin tightening and body shaping, energy devices, neuro modulators, dermal fillers, chemical peels, liposuctions, self and physician dispensed topical and injectables, removal of localized fat deposits, device-based alternatives to toxins for wrinkle reduction and therapy treatments for hair loss, excessive sweating (hyperhidrosis), malfunctioning veins (sclerotherapy) and scars. The company was founded by William McCabe in April 2015 and is headquartered in Dublin, Ireland. | - |
| Stig Lökke Pedersen | M | 62 |
moksha8 Pharmaceuticals, Inc.
moksha8 Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology moksha8 Pharmaceuticals, Inc. operates as a pharmaceutical company. It's products include viibryd, razapina, queopine, benexafrina, arasid, ziledon, zopina, and rispalum. The firm offers a portfolio of therapeutics for bipolar disorders and schizophrenia. The company was founded by Balkrishan Gill in 2007 and is headquartered in Berwyn, PA. | - |
| Joe Proctor | M | - |
Crown Laboratories, Inc.
Crown Laboratories, Inc. Pharmaceuticals: OtherHealth Technology Crown Laboratories, Inc. provides pharmaceutical and consumer products. Its products include aesthetics, beauty, therapeutic and prescription products. The firm offers contract development, manufacturing, production and packaging servicers. The company was founded by Don Kilday and Jeff Bedard in November 2000 and is headquartered in Johnson City, TN. | 6 años |
| Lauren Otsuki | F | - |
NovaCardia, Inc.
 NovaCardia, Inc. Pharmaceuticals: MajorHealth Technology NovaCardia, Inc. develops drugs to treat cardiovascular diseases. The company provides treatment for the patients by developing and commercializing clinical stage drug diseases. It also develops small molecule drugs. the company was founded in November, 2001 by Eckard Weber & Howard C. Dittrich and is headquartered in San Diego, CA. | - |
| Nick Crowe | M | - |
Crown Laboratories, Inc.
Crown Laboratories, Inc. Pharmaceuticals: OtherHealth Technology Crown Laboratories, Inc. provides pharmaceutical and consumer products. Its products include aesthetics, beauty, therapeutic and prescription products. The firm offers contract development, manufacturing, production and packaging servicers. The company was founded by Don Kilday and Jeff Bedard in November 2000 and is headquartered in Johnson City, TN. | - |
| Julian Harris | M | - |
NovaCardia, Inc.
NovaCardia, Inc. Pharmaceuticals: MajorHealth Technology NovaCardia, Inc. develops drugs to treat cardiovascular diseases. The company provides treatment for the patients by developing and commercializing clinical stage drug diseases. It also develops small molecule drugs. the company was founded in November, 2001 by Eckard Weber & Howard C. Dittrich and is headquartered in San Diego, CA. | 4 años |
| William Meury | M | 56 |
Crown Laboratories, Inc.
Crown Laboratories, Inc. Pharmaceuticals: OtherHealth Technology Crown Laboratories, Inc. provides pharmaceutical and consumer products. Its products include aesthetics, beauty, therapeutic and prescription products. The firm offers contract development, manufacturing, production and packaging servicers. The company was founded by Don Kilday and Jeff Bedard in November 2000 and is headquartered in Johnson City, TN. | - |
| Eddie de Oliveira | M | - |
Global Consolidated Aesthetics Ltd.
Global Consolidated Aesthetics Ltd. Medical SpecialtiesHealth Technology Global Consolidated Aesthetics Ltd. develops, manufactures and sells breast implants. It offers products under flagship brands Nagor and Eurosilicone. The firm manufactures products at its own facilities based in Scotland, England and France and produces to the highest European standards. The company was founded in 2007 and is headquartered in Dublin, Ireland. | - |
| Bernardo Garduño | M | - |
Global Consolidated Aesthetics Ltd.
Global Consolidated Aesthetics Ltd. Medical SpecialtiesHealth Technology Global Consolidated Aesthetics Ltd. develops, manufactures and sells breast implants. It offers products under flagship brands Nagor and Eurosilicone. The firm manufactures products at its own facilities based in Scotland, England and France and produces to the highest European standards. The company was founded in 2007 and is headquartered in Dublin, Ireland. | - |
| Stephen Hallenbeck | M | - |
Crown Laboratories, Inc.
Crown Laboratories, Inc. Pharmaceuticals: OtherHealth Technology Crown Laboratories, Inc. provides pharmaceutical and consumer products. Its products include aesthetics, beauty, therapeutic and prescription products. The firm offers contract development, manufacturing, production and packaging servicers. The company was founded by Don Kilday and Jeff Bedard in November 2000 and is headquartered in Johnson City, TN. | 7 años |
| Kimberly Stephenson | F | - |
Pure Life Renal, Inc.
Pure Life Renal, Inc. Medical/Nursing ServicesHealth Services Pure Life Renal, Inc. provides dialysis services. The firm offers the business and operational management tools along with the administrative structure that enable physicians to concentrate on care in a managed environment. The company was founded by Stefano Ciampolini in 2013 and is headquartered in Hollywood, FL. | - |
| Judith Johnson | F | - |
Pure Life Renal, Inc.
Pure Life Renal, Inc. Medical/Nursing ServicesHealth Services Pure Life Renal, Inc. provides dialysis services. The firm offers the business and operational management tools along with the administrative structure that enable physicians to concentrate on care in a managed environment. The company was founded by Stefano Ciampolini in 2013 and is headquartered in Hollywood, FL. | - |
| Emma Park | F | 54 |
Global Consolidated Aesthetics Ltd.
Global Consolidated Aesthetics Ltd. Medical SpecialtiesHealth Technology Global Consolidated Aesthetics Ltd. develops, manufactures and sells breast implants. It offers products under flagship brands Nagor and Eurosilicone. The firm manufactures products at its own facilities based in Scotland, England and France and produces to the highest European standards. The company was founded in 2007 and is headquartered in Dublin, Ireland. | 9 años |
| David Lazo | M | - |
Woodside Priory School
| - |
| Mark Stogner | M | - |
Woodside Priory School
| - |
| Rolando Crisostomo | M | - |
Woodside Priory School
| - |
| Arthur Higgins | M | 68 |
moksha8 Pharmaceuticals, Inc.
moksha8 Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology moksha8 Pharmaceuticals, Inc. operates as a pharmaceutical company. It's products include viibryd, razapina, queopine, benexafrina, arasid, ziledon, zopina, and rispalum. The firm offers a portfolio of therapeutics for bipolar disorders and schizophrenia. The company was founded by Balkrishan Gill in 2007 and is headquartered in Berwyn, PA. | - |
| Ayhan Aslan | M | - |
Global Consolidated Aesthetics Ltd.
Global Consolidated Aesthetics Ltd. Medical SpecialtiesHealth Technology Global Consolidated Aesthetics Ltd. develops, manufactures and sells breast implants. It offers products under flagship brands Nagor and Eurosilicone. The firm manufactures products at its own facilities based in Scotland, England and France and produces to the highest European standards. The company was founded in 2007 and is headquartered in Dublin, Ireland. | 20 años |
| Wael Fayad | M | - |
Crown Laboratories, Inc.
Crown Laboratories, Inc. Pharmaceuticals: OtherHealth Technology Crown Laboratories, Inc. provides pharmaceutical and consumer products. Its products include aesthetics, beauty, therapeutic and prescription products. The firm offers contract development, manufacturing, production and packaging servicers. The company was founded by Don Kilday and Jeff Bedard in November 2000 and is headquartered in Johnson City, TN. | 4 años |
| Stefano L. Sola | M | 53 |
Pure Life Renal, Inc.
Pure Life Renal, Inc. Medical/Nursing ServicesHealth Services Pure Life Renal, Inc. provides dialysis services. The firm offers the business and operational management tools along with the administrative structure that enable physicians to concentrate on care in a managed environment. The company was founded by Stefano Ciampolini in 2013 and is headquartered in Hollywood, FL. | - |
| Declan McKeon | M | 68 |
Global Consolidated Aesthetics Ltd.
Global Consolidated Aesthetics Ltd. Medical SpecialtiesHealth Technology Global Consolidated Aesthetics Ltd. develops, manufactures and sells breast implants. It offers products under flagship brands Nagor and Eurosilicone. The firm manufactures products at its own facilities based in Scotland, England and France and produces to the highest European standards. The company was founded in 2007 and is headquartered in Dublin, Ireland. | 9 años |
| Spence McClelland | M | - |
Pure Life Renal, Inc.
Pure Life Renal, Inc. Medical/Nursing ServicesHealth Services Pure Life Renal, Inc. provides dialysis services. The firm offers the business and operational management tools along with the administrative structure that enable physicians to concentrate on care in a managed environment. The company was founded by Stefano Ciampolini in 2013 and is headquartered in Hollywood, FL. | 10 años |
| Ian Crosbie | M | 56 |
Global Consolidated Aesthetics Ltd.
Global Consolidated Aesthetics Ltd. Medical SpecialtiesHealth Technology Global Consolidated Aesthetics Ltd. develops, manufactures and sells breast implants. It offers products under flagship brands Nagor and Eurosilicone. The firm manufactures products at its own facilities based in Scotland, England and France and produces to the highest European standards. The company was founded in 2007 and is headquartered in Dublin, Ireland. | 9 años |
| Barry Hatt | M | 68 |
Global Consolidated Aesthetics Ltd.
Global Consolidated Aesthetics Ltd. Medical SpecialtiesHealth Technology Global Consolidated Aesthetics Ltd. develops, manufactures and sells breast implants. It offers products under flagship brands Nagor and Eurosilicone. The firm manufactures products at its own facilities based in Scotland, England and France and produces to the highest European standards. The company was founded in 2007 and is headquartered in Dublin, Ireland. | 16 años |
| Michael J. Mayer | M | - |
Montreux Equity Partners, Inc.
Montreux Equity Partners, Inc. Investment ManagersFinance Montreux Equity Partners, Inc. (Montreux Equity Partners) is a Venture Capital firm founded in 1993 by Dan K. Turner. The firm is headquartered in San Francisco, California. | - |
| Julia Marsan | F | 62 |
Global Consolidated Aesthetics Ltd.
Global Consolidated Aesthetics Ltd. Medical SpecialtiesHealth Technology Global Consolidated Aesthetics Ltd. develops, manufactures and sells breast implants. It offers products under flagship brands Nagor and Eurosilicone. The firm manufactures products at its own facilities based in Scotland, England and France and produces to the highest European standards. The company was founded in 2007 and is headquartered in Dublin, Ireland. | 11 años |
| David G. Lowe | M | 67 |
NovaCardia, Inc.
NovaCardia, Inc. Pharmaceuticals: MajorHealth Technology NovaCardia, Inc. develops drugs to treat cardiovascular diseases. The company provides treatment for the patients by developing and commercializing clinical stage drug diseases. It also develops small molecule drugs. the company was founded in November, 2001 by Eckard Weber & Howard C. Dittrich and is headquartered in San Diego, CA. | 18 años |
| Tom Fremd | M | - |
Montreux Equity Partners, Inc.
Montreux Equity Partners, Inc. Investment ManagersFinance Montreux Equity Partners, Inc. (Montreux Equity Partners) is a Venture Capital firm founded in 1993 by Dan K. Turner. The firm is headquartered in San Francisco, California. | - |
| Adair Newhall | M | 45 |
Crown Laboratories, Inc.
Crown Laboratories, Inc. Pharmaceuticals: OtherHealth Technology Crown Laboratories, Inc. provides pharmaceutical and consumer products. Its products include aesthetics, beauty, therapeutic and prescription products. The firm offers contract development, manufacturing, production and packaging servicers. The company was founded by Don Kilday and Jeff Bedard in November 2000 and is headquartered in Johnson City, TN. | - |
| Allen Moseley | M | 54 |
Pure Life Renal, Inc.
Pure Life Renal, Inc. Medical/Nursing ServicesHealth Services Pure Life Renal, Inc. provides dialysis services. The firm offers the business and operational management tools along with the administrative structure that enable physicians to concentrate on care in a managed environment. The company was founded by Stefano Ciampolini in 2013 and is headquartered in Hollywood, FL. | 10 años |
| Steve Krausz | M | 69 |
Woodside Priory School
| - |
| Patrick Ruff | M | - |
Woodside Priory School
| - |
Gráfico relacional
Relaciones con varias empresas
Antiguas relaciones
| Nombre | Sexo | Edad | Empresas relacionadas | Colaboración |
|---|---|---|---|---|
| Glenn A. Oclassen | M | 81 |
Transcept Pharmaceuticals, Inc. (Old)
 Transcept Pharmaceuticals, Inc. (Old) Pharmaceuticals: MajorHealth Technology Transcept Pharmaceuticals, Inc. researches and develops biopharmaceutical products. The firm's products are used for pain, side effects of chemotherapy treatments, sleeplessness, and migraine headaches. Its drug delivery technology enhances absorption rates of active drug agents reduces absorption times. The company was founded in January, 2002 by Nikhilesh Singh and is headquartered in Pt. Richmond, CA.
Transcept Pharma, Inc.
 Transcept Pharma, Inc. Pharmaceuticals: MajorHealth Technology Transcept Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on the development and commercialization of proprietary products that address important therapeutic needs in the field of neuroscience. Its product pipeline is TO-2070, a novel, rapidly absorbed treatment for acute migraine incorporating dihydroergotamine as the active drug. The company was founded on January 30, 2009 and is headquartered in Point Richmond, CA. | 8 años |
| Richard Pascoe | M | 60 |
Somaxon Pharmaceuticals, Inc.
 Somaxon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Somaxon Pharmaceuticals, Inc. is a specialty pharmaceutical company. The company focuses on the in-licensing, development and commercialization of proprietary branded products and product candidates to treat important medical conditions where there is an unmet medical need and high-level of patient dissatisfaction, currently in the central nervous system therapeutic area. Its product, Silenor, is indicated for the treatment of insomnia characterized by difficulty with sleep maintenance. Somaxon Pharmaceuticals was founded in August 2003 and is headquartered in Solana Beach, CA. | 5 años |
| G. Kirk Raab | M | 88 |
Transcept Pharmaceuticals, Inc. (Old)
Transcept Pharmaceuticals, Inc. (Old) Pharmaceuticals: MajorHealth Technology Transcept Pharmaceuticals, Inc. researches and develops biopharmaceutical products. The firm's products are used for pain, side effects of chemotherapy treatments, sleeplessness, and migraine headaches. Its drug delivery technology enhances absorption rates of active drug agents reduces absorption times. The company was founded in January, 2002 by Nikhilesh Singh and is headquartered in Pt. Richmond, CA.
Transcept Pharma, Inc.
Transcept Pharma, Inc. Pharmaceuticals: MajorHealth Technology Transcept Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on the development and commercialization of proprietary products that address important therapeutic needs in the field of neuroscience. Its product pipeline is TO-2070, a novel, rapidly absorbed treatment for acute migraine incorporating dihydroergotamine as the active drug. The company was founded on January 30, 2009 and is headquartered in Point Richmond, CA. | 6 años |
| Michael Narachi | M | 64 | 9 años | |
| Louis C. Bock | M | 59 |
Somaxon Pharmaceuticals, Inc.
Somaxon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Somaxon Pharmaceuticals, Inc. is a specialty pharmaceutical company. The company focuses on the in-licensing, development and commercialization of proprietary branded products and product candidates to treat important medical conditions where there is an unmet medical need and high-level of patient dissatisfaction, currently in the central nervous system therapeutic area. Its product, Silenor, is indicated for the treatment of insomnia characterized by difficulty with sleep maintenance. Somaxon Pharmaceuticals was founded in August 2003 and is headquartered in Solana Beach, CA. | 13 años |
| Thomas D. Kiley | M | 80 |
Transcept Pharmaceuticals, Inc. (Old)
Transcept Pharmaceuticals, Inc. (Old) Pharmaceuticals: MajorHealth Technology Transcept Pharmaceuticals, Inc. researches and develops biopharmaceutical products. The firm's products are used for pain, side effects of chemotherapy treatments, sleeplessness, and migraine headaches. Its drug delivery technology enhances absorption rates of active drug agents reduces absorption times. The company was founded in January, 2002 by Nikhilesh Singh and is headquartered in Pt. Richmond, CA.
Transcept Pharma, Inc.
Transcept Pharma, Inc. Pharmaceuticals: MajorHealth Technology Transcept Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on the development and commercialization of proprietary products that address important therapeutic needs in the field of neuroscience. Its product pipeline is TO-2070, a novel, rapidly absorbed treatment for acute migraine incorporating dihydroergotamine as the active drug. The company was founded on January 30, 2009 and is headquartered in Point Richmond, CA. | 5 años |
| Kathy LaPorte | F | 62 |
Transcept Pharmaceuticals, Inc. (Old)
Transcept Pharmaceuticals, Inc. (Old) Pharmaceuticals: MajorHealth Technology Transcept Pharmaceuticals, Inc. researches and develops biopharmaceutical products. The firm's products are used for pain, side effects of chemotherapy treatments, sleeplessness, and migraine headaches. Its drug delivery technology enhances absorption rates of active drug agents reduces absorption times. The company was founded in January, 2002 by Nikhilesh Singh and is headquartered in Pt. Richmond, CA.
Transcept Pharma, Inc.
Transcept Pharma, Inc. Pharmaceuticals: MajorHealth Technology Transcept Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on the development and commercialization of proprietary products that address important therapeutic needs in the field of neuroscience. Its product pipeline is TO-2070, a novel, rapidly absorbed treatment for acute migraine incorporating dihydroergotamine as the active drug. The company was founded on January 30, 2009 and is headquartered in Point Richmond, CA. | 7 años |
| Thomas Wiggans | M | 72 |
Somaxon Pharmaceuticals, Inc.
Somaxon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Somaxon Pharmaceuticals, Inc. is a specialty pharmaceutical company. The company focuses on the in-licensing, development and commercialization of proprietary branded products and product candidates to treat important medical conditions where there is an unmet medical need and high-level of patient dissatisfaction, currently in the central nervous system therapeutic area. Its product, Silenor, is indicated for the treatment of insomnia characterized by difficulty with sleep maintenance. Somaxon Pharmaceuticals was founded in August 2003 and is headquartered in Solana Beach, CA. | 4 años |
| Patrick Mahaffy | M | 61 | 9 años | |
| Manish Chapekar | M | - |
Montreux Equity Partners, Inc.
Montreux Equity Partners, Inc. Investment ManagersFinance Montreux Equity Partners, Inc. (Montreux Equity Partners) is a Venture Capital firm founded in 1993 by Dan K. Turner. The firm is headquartered in San Francisco, California. | 10 años |
| Nikhilesh N. Singh | M | 65 |
Transcept Pharmaceuticals, Inc. (Old)
Transcept Pharmaceuticals, Inc. (Old) Pharmaceuticals: MajorHealth Technology Transcept Pharmaceuticals, Inc. researches and develops biopharmaceutical products. The firm's products are used for pain, side effects of chemotherapy treatments, sleeplessness, and migraine headaches. Its drug delivery technology enhances absorption rates of active drug agents reduces absorption times. The company was founded in January, 2002 by Nikhilesh Singh and is headquartered in Pt. Richmond, CA.
Transcept Pharma, Inc.
Transcept Pharma, Inc. Pharmaceuticals: MajorHealth Technology Transcept Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on the development and commercialization of proprietary products that address important therapeutic needs in the field of neuroscience. Its product pipeline is TO-2070, a novel, rapidly absorbed treatment for acute migraine incorporating dihydroergotamine as the active drug. The company was founded on January 30, 2009 and is headquartered in Point Richmond, CA. | 8 años |
| Dennis D. Kim | M | 54 | 3 años | |
| Lota Zoth | F | 64 | 7 años | |
| Suzanne McDonald | F | 71 | - | |
| Marilyn E. Wortzman | F | 77 |
Transcept Pharmaceuticals, Inc. (Old)
Transcept Pharmaceuticals, Inc. (Old) Pharmaceuticals: MajorHealth Technology Transcept Pharmaceuticals, Inc. researches and develops biopharmaceutical products. The firm's products are used for pain, side effects of chemotherapy treatments, sleeplessness, and migraine headaches. Its drug delivery technology enhances absorption rates of active drug agents reduces absorption times. The company was founded in January, 2002 by Nikhilesh Singh and is headquartered in Pt. Richmond, CA.
Transcept Pharma, Inc.
Transcept Pharma, Inc. Pharmaceuticals: MajorHealth Technology Transcept Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on the development and commercialization of proprietary products that address important therapeutic needs in the field of neuroscience. Its product pipeline is TO-2070, a novel, rapidly absorbed treatment for acute migraine incorporating dihydroergotamine as the active drug. The company was founded on January 30, 2009 and is headquartered in Point Richmond, CA. | 5 años |
| Kenneth M. Cohen | M | 68 |
Somaxon Pharmaceuticals, Inc.
Somaxon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Somaxon Pharmaceuticals, Inc. is a specialty pharmaceutical company. The company focuses on the in-licensing, development and commercialization of proprietary branded products and product candidates to treat important medical conditions where there is an unmet medical need and high-level of patient dissatisfaction, currently in the central nervous system therapeutic area. Its product, Silenor, is indicated for the treatment of insomnia characterized by difficulty with sleep maintenance. Somaxon Pharmaceuticals was founded in August 2003 and is headquartered in Solana Beach, CA. | 5 años |
| Sharon Sakai | M | - |
Transcept Pharmaceuticals, Inc. (Old)
Transcept Pharmaceuticals, Inc. (Old) Pharmaceuticals: MajorHealth Technology Transcept Pharmaceuticals, Inc. researches and develops biopharmaceutical products. The firm's products are used for pain, side effects of chemotherapy treatments, sleeplessness, and migraine headaches. Its drug delivery technology enhances absorption rates of active drug agents reduces absorption times. The company was founded in January, 2002 by Nikhilesh Singh and is headquartered in Pt. Richmond, CA.
Transcept Pharma, Inc.
Transcept Pharma, Inc. Pharmaceuticals: MajorHealth Technology Transcept Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on the development and commercialization of proprietary products that address important therapeutic needs in the field of neuroscience. Its product pipeline is TO-2070, a novel, rapidly absorbed treatment for acute migraine incorporating dihydroergotamine as the active drug. The company was founded on January 30, 2009 and is headquartered in Point Richmond, CA. | 8 años |
| Frederick J. Ruegsegger | M | 68 |
Transcept Pharma, Inc.
Transcept Pharma, Inc. Pharmaceuticals: MajorHealth Technology Transcept Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on the development and commercialization of proprietary products that address important therapeutic needs in the field of neuroscience. Its product pipeline is TO-2070, a novel, rapidly absorbed treatment for acute migraine incorporating dihydroergotamine as the active drug. The company was founded on January 30, 2009 and is headquartered in Point Richmond, CA. | - |
| Camille Samuels | F | 52 |
Transcept Pharma, Inc.
Transcept Pharma, Inc. Pharmaceuticals: MajorHealth Technology Transcept Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on the development and commercialization of proprietary products that address important therapeutic needs in the field of neuroscience. Its product pipeline is TO-2070, a novel, rapidly absorbed treatment for acute migraine incorporating dihydroergotamine as the active drug. The company was founded on January 30, 2009 and is headquartered in Point Richmond, CA. | 2 años |
| Kurt von Emster | M | 56 |
Somaxon Pharmaceuticals, Inc.
Somaxon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Somaxon Pharmaceuticals, Inc. is a specialty pharmaceutical company. The company focuses on the in-licensing, development and commercialization of proprietary branded products and product candidates to treat important medical conditions where there is an unmet medical need and high-level of patient dissatisfaction, currently in the central nervous system therapeutic area. Its product, Silenor, is indicated for the treatment of insomnia characterized by difficulty with sleep maintenance. Somaxon Pharmaceuticals was founded in August 2003 and is headquartered in Solana Beach, CA. | 8 años |
| Jake Nunn | M | 53 |
Transcept Pharma, Inc.
Transcept Pharma, Inc. Pharmaceuticals: MajorHealth Technology Transcept Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on the development and commercialization of proprietary products that address important therapeutic needs in the field of neuroscience. Its product pipeline is TO-2070, a novel, rapidly absorbed treatment for acute migraine incorporating dihydroergotamine as the active drug. The company was founded on January 30, 2009 and is headquartered in Point Richmond, CA. | - |
| Erle T. Mast | M | 61 |
Somaxon Pharmaceuticals, Inc.
Somaxon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Somaxon Pharmaceuticals, Inc. is a specialty pharmaceutical company. The company focuses on the in-licensing, development and commercialization of proprietary branded products and product candidates to treat important medical conditions where there is an unmet medical need and high-level of patient dissatisfaction, currently in the central nervous system therapeutic area. Its product, Silenor, is indicated for the treatment of insomnia characterized by difficulty with sleep maintenance. Somaxon Pharmaceuticals was founded in August 2003 and is headquartered in Solana Beach, CA. | 5 años |
| McDavid Stilwell | M | 53 | 4 años | |
| Michael Powell | M | 69 | 8 años | |
| Cam Garner | M | 75 |
Somaxon Pharmaceuticals, Inc.
Somaxon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Somaxon Pharmaceuticals, Inc. is a specialty pharmaceutical company. The company focuses on the in-licensing, development and commercialization of proprietary branded products and product candidates to treat important medical conditions where there is an unmet medical need and high-level of patient dissatisfaction, currently in the central nervous system therapeutic area. Its product, Silenor, is indicated for the treatment of insomnia characterized by difficulty with sleep maintenance. Somaxon Pharmaceuticals was founded in August 2003 and is headquartered in Solana Beach, CA. | - |
| Neil Sunderland | M | 79 |
Montreux Equity Partners, Inc.
Montreux Equity Partners, Inc. Investment ManagersFinance Montreux Equity Partners, Inc. (Montreux Equity Partners) is a Venture Capital firm founded in 1993 by Dan K. Turner. The firm is headquartered in San Francisco, California. | - |
| Scott Glenn | M | 73 |
Somaxon Pharmaceuticals, Inc.
Somaxon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Somaxon Pharmaceuticals, Inc. is a specialty pharmaceutical company. The company focuses on the in-licensing, development and commercialization of proprietary branded products and product candidates to treat important medical conditions where there is an unmet medical need and high-level of patient dissatisfaction, currently in the central nervous system therapeutic area. Its product, Silenor, is indicated for the treatment of insomnia characterized by difficulty with sleep maintenance. Somaxon Pharmaceuticals was founded in August 2003 and is headquartered in Solana Beach, CA. | 4 años |
| Peter Honig | M | 67 | 8 años | |
| Joseph T. Kennedy | M | 56 |
Transcept Pharma, Inc.
Transcept Pharma, Inc. Pharmaceuticals: MajorHealth Technology Transcept Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on the development and commercialization of proprietary products that address important therapeutic needs in the field of neuroscience. Its product pipeline is TO-2070, a novel, rapidly absorbed treatment for acute migraine incorporating dihydroergotamine as the active drug. The company was founded on January 30, 2009 and is headquartered in Point Richmond, CA. | 2 años |
| Terrence O. Moore | M | 69 |
Transcept Pharmaceuticals, Inc. (Old)
Transcept Pharmaceuticals, Inc. (Old) Pharmaceuticals: MajorHealth Technology Transcept Pharmaceuticals, Inc. researches and develops biopharmaceutical products. The firm's products are used for pain, side effects of chemotherapy treatments, sleeplessness, and migraine headaches. Its drug delivery technology enhances absorption rates of active drug agents reduces absorption times. The company was founded in January, 2002 by Nikhilesh Singh and is headquartered in Pt. Richmond, CA.
Transcept Pharma, Inc.
Transcept Pharma, Inc. Pharmaceuticals: MajorHealth Technology Transcept Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on the development and commercialization of proprietary products that address important therapeutic needs in the field of neuroscience. Its product pipeline is TO-2070, a novel, rapidly absorbed treatment for acute migraine incorporating dihydroergotamine as the active drug. The company was founded on January 30, 2009 and is headquartered in Point Richmond, CA. | 3 años |
| Heather Turner | F | 51 | 8 años | |
| Ronald P. Landbloom | M | 77 | - | |
| Wendy Dixon | M | 68 | 6 años | |
| Graham Cooper | M | 54 | 5 años | |
| Joseph Hagan | M | 55 | 6 años | |
| Joseph Lacob | M | 68 | 8 años | |
| Brian Dorsey | M | 55 |
Somaxon Pharmaceuticals, Inc.
Somaxon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Somaxon Pharmaceuticals, Inc. is a specialty pharmaceutical company. The company focuses on the in-licensing, development and commercialization of proprietary branded products and product candidates to treat important medical conditions where there is an unmet medical need and high-level of patient dissatisfaction, currently in the central nervous system therapeutic area. Its product, Silenor, is indicated for the treatment of insomnia characterized by difficulty with sleep maintenance. Somaxon Pharmaceuticals was founded in August 2003 and is headquartered in Solana Beach, CA. | 8 años |
| Matthew Onaitis | M | 53 |
Somaxon Pharmaceuticals, Inc.
Somaxon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Somaxon Pharmaceuticals, Inc. is a specialty pharmaceutical company. The company focuses on the in-licensing, development and commercialization of proprietary branded products and product candidates to treat important medical conditions where there is an unmet medical need and high-level of patient dissatisfaction, currently in the central nervous system therapeutic area. Its product, Silenor, is indicated for the treatment of insomnia characterized by difficulty with sleep maintenance. Somaxon Pharmaceuticals was founded in August 2003 and is headquartered in Solana Beach, CA. | 7 años |
| Susan L. Koppy | F | 62 |
Transcept Pharmaceuticals, Inc. (Old)
Transcept Pharmaceuticals, Inc. (Old) Pharmaceuticals: MajorHealth Technology Transcept Pharmaceuticals, Inc. researches and develops biopharmaceutical products. The firm's products are used for pain, side effects of chemotherapy treatments, sleeplessness, and migraine headaches. Its drug delivery technology enhances absorption rates of active drug agents reduces absorption times. The company was founded in January, 2002 by Nikhilesh Singh and is headquartered in Pt. Richmond, CA.
Transcept Pharma, Inc.
Transcept Pharma, Inc. Pharmaceuticals: MajorHealth Technology Transcept Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on the development and commercialization of proprietary products that address important therapeutic needs in the field of neuroscience. Its product pipeline is TO-2070, a novel, rapidly absorbed treatment for acute migraine incorporating dihydroergotamine as the active drug. The company was founded on January 30, 2009 and is headquartered in Point Richmond, CA. | 1 años |
| Christopher Ehrlich | M | 54 |
Transcept Pharma, Inc.
Transcept Pharma, Inc. Pharmaceuticals: MajorHealth Technology Transcept Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on the development and commercialization of proprietary products that address important therapeutic needs in the field of neuroscience. Its product pipeline is TO-2070, a novel, rapidly absorbed treatment for acute migraine incorporating dihydroergotamine as the active drug. The company was founded on January 30, 2009 and is headquartered in Point Richmond, CA. | 4 años |
| Gary D. Tollefson | M | 72 | 3 años | |
| Nipun Davar | M | - |
Transcept Pharmaceuticals, Inc. (Old)
Transcept Pharmaceuticals, Inc. (Old) Pharmaceuticals: MajorHealth Technology Transcept Pharmaceuticals, Inc. researches and develops biopharmaceutical products. The firm's products are used for pain, side effects of chemotherapy treatments, sleeplessness, and migraine headaches. Its drug delivery technology enhances absorption rates of active drug agents reduces absorption times. The company was founded in January, 2002 by Nikhilesh Singh and is headquartered in Pt. Richmond, CA. | 3 años |
| Dawn Viveash | M | 68 | - | |
| Greg Baty | M | - |
Montreux Equity Partners, Inc.
Montreux Equity Partners, Inc. Investment ManagersFinance Montreux Equity Partners, Inc. (Montreux Equity Partners) is a Venture Capital firm founded in 1993 by Dan K. Turner. The firm is headquartered in San Francisco, California. | 4 años |
| Michael C. Scaife | M | - | - | |
| John P. Walker | M | 75 |
Transcept Pharma, Inc.
Transcept Pharma, Inc. Pharmaceuticals: MajorHealth Technology Transcept Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on the development and commercialization of proprietary products that address important therapeutic needs in the field of neuroscience. Its product pipeline is TO-2070, a novel, rapidly absorbed treatment for acute migraine incorporating dihydroergotamine as the active drug. The company was founded on January 30, 2009 and is headquartered in Point Richmond, CA. | 2 años |
| Murray C. Maytom | M | - |
Transcept Pharmaceuticals, Inc. (Old)
Transcept Pharmaceuticals, Inc. (Old) Pharmaceuticals: MajorHealth Technology Transcept Pharmaceuticals, Inc. researches and develops biopharmaceutical products. The firm's products are used for pain, side effects of chemotherapy treatments, sleeplessness, and migraine headaches. Its drug delivery technology enhances absorption rates of active drug agents reduces absorption times. The company was founded in January, 2002 by Nikhilesh Singh and is headquartered in Pt. Richmond, CA. | 2 años |
| Walter Piskorski | M | 75 | - | |
| Sue Monjauze | F | - |
Montreux Equity Partners, Inc.
Montreux Equity Partners, Inc. Investment ManagersFinance Montreux Equity Partners, Inc. (Montreux Equity Partners) is a Venture Capital firm founded in 1993 by Dan K. Turner. The firm is headquartered in San Francisco, California. | - |
| Michael A. Cowley | M | 55 | 2 años | |
| Thomas Soloway | M | 55 |
Montreux Equity Partners, Inc.
Montreux Equity Partners, Inc. Investment ManagersFinance Montreux Equity Partners, Inc. (Montreux Equity Partners) is a Venture Capital firm founded in 1993 by Dan K. Turner. The firm is headquartered in San Francisco, California. | 9 años |
| Anthony DiTonno | M | 75 |
Oclassen Pharmaceuticals, Inc.
 Oclassen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Oclassen Pharmaceuticals Inc, headquartered in San Rafael, CA develops and markets specialty pharmaceuticals for the prevention, diagnosis and treatment of skin diseases. Oclassen Pharmaceuticals develops and markets products for the dermatology and wound-care markets. | 8 años |
| John J. Savarese | M | 55 |
Montreux Equity Partners, Inc.
Montreux Equity Partners, Inc. Investment ManagersFinance Montreux Equity Partners, Inc. (Montreux Equity Partners) is a Venture Capital firm founded in 1993 by Dan K. Turner. The firm is headquartered in San Francisco, California. | 13 años |
| Mark D. Booth | M | 64 | 6 años | |
| James C. Lancaster | M | 77 | 2 años | |
| Franklin P. Bymaster | M | 78 | 2 años | |
| Howard D. Palefsky | M | - |
Montreux Equity Partners, Inc.
Montreux Equity Partners, Inc. Investment ManagersFinance Montreux Equity Partners, Inc. (Montreux Equity Partners) is a Venture Capital firm founded in 1993 by Dan K. Turner. The firm is headquartered in San Francisco, California. | 13 años |
| Patricia Bitar | F | 65 | 2 años |
Estadísticas
| País | Relaciones | % del total |
|---|---|---|
| Estados Unidos | 90 | 90.00% |
| Irlanda | 11 | 11.00% |
Antigüedad de la relación
Activas
Pasados
Hombre
Mujer
Administradores
Ejecutivos
Origen de las relaciones
- Bolsa de valores
- Insiders
- Dan Turner
- Red Personal
